Should I buy Brown–Forman (BF-B) stock or is it too late?

Brown–Forman · Consumer Staples · price $27

See the full Brown–Forman (BF-B) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (262 calls tested). It aims for $30 (+9.9 %), call made on September 5, 2026, maturing on September 5, 2027 (39 d ago).

The 4 reliable analysts $27.50+0.8 %

The 4 other firms $28.50+4.4 %

How to read it: the 4 reliable firms are not filtered by optimism — 2 aim above the price, 2 below, hence their $27.50 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Brown–Forman

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	100 %	+16.9 %	5	$25 -8%
Barclays	0 %	-18.4 %	11	$28 +3%

In short — Should you invest in Brown–Forman? Is it too late, still worth it? Analysts are split (0% buy, median target $28, i.e. +3%), and the most reliable on BF-B targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on BF-B, UBS (100% hit rate, 3 scored calls), targets $30 (call made on September 4, 2026, maturing on September 4, 2027) (+10%) in its most recent call, and $30 (call made on February 26, 2026, maturing on February 26, 2027) (+10%) in the one coming due soonest.
Pays a dividend (3.6% yield) — regular income on top of potential upside.
Reasonable valuation (P/E ~17) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 6 are neutral and 2 are sells.
Limited upside: the median target is only +3% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on BF-B

Median target $28 (+3%) · 8 ratings · Hold consensus

Strong Buy00%

Buy00%

Hold675%

Sell225%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Brown–Forman now?

We won't decide for you. The facts: 0% of analysts rate it a buy, median target $28 (+3%), and UBS (most reliable on BF-B, 100%) targets $30. Weigh that against valuation (P/E ~17). This is not personalized advice.

Is it too late to invest in Brown–Forman?

The stated upside is small: the median target ($28) sits just +3% from the price ($27) (most reliable on BF-B: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Brown–Forman still worth investing in?

It depends on the gap between the price ($27) and its estimated value: analysts target $28 on median (+3%), with 0% buys (most reliable on BF-B: UBS, 100%). Cross-check with their real reliability on BF-B and the cautions above. Information, not advice.

What's the main risk in buying BF-B?

The consensus is not unanimous: of 8 ratings, 6 are neutral and 2 are sells.

→ Go deeper: the full Brown–Forman profile (consensus, analyst reliability, price target, performance).